Akoya Biosciences and Argonaut Expand collaboration for IVD Development

Argonaut Manufacturing Services, a contract development and manufacturing organization catering to the biopharma and life sciences sectors, has been chosen as the manufacturing partner for Akoya Biosciences Inc.’s IVD assays that are under development. This agreement is founded on years of teamwork between Argonaut and Akoya, showcasing Argonaut's capability to assist both nascent and established diagnostic product lines. 

Additionally, this broadened partnership highlights both organizations' dedication to promoting precision medicine via top-notch diagnostics.

“Argonaut and Akoya have built a trusted relationship over the years,” said Wayne Woodard, Founder and CEO of Argonaut. “We’ve successfully supported their Research Use only (RUO) portfolio, and we are thrilled to extend this partnership into the highly regulated companion diagnostic space. Akoya’s innovative solutions in spatial biology are shaping the future of precision medicine, and we are proud to play a role in bringing their vision to life.”

“Our spatial phenotyping technology and PhenoImager platform are demonstrating robust diagnostic capabilities for patient selection,” commented Brian McKelligon, CEO of Akoya. “Our partnership with Argonaut is centered around delivering high-quality IVD products to our clients, manufactured under strict cGMP and ISO 13485:2016 requirements. Argonaut’s deep expertise and reliable systems make them an invaluable partner as we scale to meet the demand of the market.”